tirzepatide weight loss percentage surmount trials Tirzepatide: In the SURMOUNT-1 trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 Presented today at #ECO2026 ⤵️
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5






-treatments-cpap-vs-tirzepatide-seo-graphics-audra-(1).png?sfvrsn=cf995197_3)



.png)















